Global Recombinant Protein Market Report

Global recombinant protein market

DUBLIN, April 2, 2024 (GLOBE NEWSWIRE) — By product (growth factors, chemokines, structural proteins, membrane proteins), by application (drug discovery and development (biologics, vaccines, cell and gene therapies), research , Biopharmaceutical Production) and Regions – Forecast to 2028” report added ResearchAndMarkets.com Recruitment.

The global recombinant protein market size is projected to reach USD 3.2 billion by 2028 from USD 2.2 billion in 2023, at a CAGR of 7.2% during the forecast period. Factors include increased demand for biologics and biosimilars due to patent expirations, increasing prevalence of chronic diseases, increased government support for life sciences research and development, and a growing preference for personalized medicine.

Growth factors and chemokines segment holds dominant share in recombinant protein market

Based on products, the global recombinant protein market has been segmented into growth factors and chemokines, kinase proteins, membrane proteins, immune response proteins, structural proteins, regulatory proteins, recombinant metabolic enzymes, adhesion molecules and receptors, and other recombinant It is classified as a protein. The growth factors and chemokines segment is further classified into interferons, interleukins, and other growth factors and chemokines. The growth factors and chemokines segment is expected to grow at a significant CAGR due to applications in cell culture, protein expression, and modulation of cellular responses.

Drug discovery and development segment will account for largest share of application segment in 2022

Based on application, the recombinant protein market is segmented into drug discovery and development, biopharmaceutical production, research, diagnostics, and other applications. In 2022, the drug discovery and development segment held the largest share in the recombinant protein market. This segment held the largest share in the market due to the application of recombinant proteins in the development of biopharmaceuticals and understanding the functions of potential drug targets.

Asia Pacific region is likely to grow at a faster pace in the recombinant protein market

The recombinant protein market region is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is expected to grow at a significant CAGR during the forecast period. Growth in the region is primarily driven by increasing demand for protein-based medicines, increased government funding for recombinant protein production and biotechnology-based medicine development.

This report provides insights such as:

story continues

• Analysis of key factors (increasing incidence of chronic diseases, innovation in biologics and biosimilars due to patent expiry, increasing government support for R&D in life sciences, increasing preference for personalized medicine), constraints (high production costs, stringent regulatory approval processes), opportunities (advances in gene editing technology, high growth potential in emerging markets, emergence of new expression systems) and challenges (challenges related to delivery systems). impacting the growth of the engineered protein market.

• Product Development/Innovation: Detailed insights on newly launched products in the recombinant protein market.

• Market Development: Comprehensive Information on Profitable Market – This report analyzes the Recombinant Protein Market across various regions.

• Market Diversification: Thorough information on new products, unexplored regions, recent developments, and investments in the Recombinant Protein Market.

• Competitive assessment: Detailed market share, growth strategies, and service offerings of key players such as Bio-Techne (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Abcam plc (UK), and Abnova. Evaluation Corporation (Taiwan), Biolegend Inc. (USA), Bio-Rad Laboratories Inc. (USA), BPS Bioscienc Inc. (USA), Enzo Biochem Inc. (USA), and GenScript (China).

Key attributes:

Main topics covered:

executive summary

• Recombinant Protein Market, By Product, 2023 vs. 2028 (USD Million)

• Recombinant Protein Market, By Application, 2023 vs. 2028 (USD Million)

• Recombinant Proteins for Drug Discovery and Development Market, by Type, 2023 vs. 2028 (USD Million)

• Research Recombinant Protein Market, By Type, 2023 vs. 2028 (USD Million)

• Recombinant Protein Market, By Host Cell, 2023 vs. 2028 (USD Million)

• Recombinant Protein Market, By End User, 2023 vs 2028 (USD Million)

• Geographic snapshot of recombinant protein market

premium insights

• Recombinant Protein Market Overview – Increased Government Support for Life Sciences R&D to Drive Market

• North America: Recombinant Protein Market, by Product (2022) – Growth Factors and Chemokines Sector to Account for Largest Market Share in 2022

• Recombinant Protein Market, by Product, 2023 vs. 2028 – Growth Factors and Chemokines Segment Dominates the Market During the Forecast Period

• Recombinant Protein Market: Geographic Growth Opportunities – Asia Pacific countries register highest growth rate during forecast period

Market trend

driver

• Increased incidence of chronic diseases

• Increased demand for biologics and biosimilars due to patent expiration

• Strengthening government support for research and development in the life sciences field

• Growing interest in personalized medicine

restraints

opportunity

• Advances in gene editing technology

• High growth potential in emerging markets

• Emergence of new expression system

assignment

Introduced companies

• biotechne

• Thermo Fisher Scientific Co., Ltd.

• Merck KGaA

• Abcam PLC

• Abunova Co., Ltd.

• Biolegend Co., Ltd.

• Bio-Rad Laboratories, Inc.

• BPS Bioscience Co., Ltd.

• Enzo Life Sciences

• genscript

• Miltenyi Biotech BV & Co. KG

• Proteintech Group Co., Ltd.

• Sino Biological Co., Ltd.

• Acrobiosystems Group

• Aviva System Biology

• sartorius celgenics

• Icosagen

• neuromics

• Prospec Tunny Technogene Co., Ltd.

• Proteogenics SAS

• Ray Biotech Co., Ltd.

• Laurus Biography

• stem cell technologies

• Stress Mark Bioscience Co., Ltd.

• us biological

For more information on this report, please visit https://www.researchandmarkets.com/r/4n1g8d.

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.

attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900